10 drug(s) with this reaction
34,288 total reports
Weight Increased has been reported as an adverse reaction across 10 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 34,288 adverse event reports mention weight increased in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with weight increased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have weight increased listed in their FDA adverse event reports, sorted by report count:
In addition to weight increased, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
10 drug(s) manufactured by Abbvie Inc have weight increased listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, UPADACITINIB, and others.
There are a combined 34,288 reports of weight increased across 10 Abbvie Inc drug(s) in the FDA adverse event database.